NEW YORK, Aug. 22 (GenomeWeb News) - Invitrogen announced today that it had completed its acquisition of Molecular Probes.
"As a leader in life sciences consumables, we believe that Invitrogen's worldwide sales, marketing and distribution capabilities will accelerate the penetration of Molecular Probes' core technologies into new markets," said Invitrogen CEO Greg Lucier in a statement that also reaffirmed the company's financial guidance for 2003.